Patents by Inventor David J. Sloan

David J. Sloan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180059131
    Abstract: Disclosed are fluidics devices and assemblies allowing for fluid flow between a plurality of wells. The fluidics devices and assemblies that are provided mimic in vivo tissue environments by allowing for initially segregated tissue cultures that can then be linked through fluid flow to measure integrated tissue response. The fluidics devices and assemblies provide a pumpless system using surface tension, gravity, and channel geometries. By linking human tissue functional systems to better simulate in vivo feedback and response signals between the tissues, the need for testing in animals can be minimized.
    Type: Application
    Filed: October 25, 2017
    Publication date: March 1, 2018
    Inventors: Randall Edwin McClelland, David J. Sloan, Timothy C. Jensen, Maureen Kay Bunger
  • Patent number: 9829499
    Abstract: Disclosed are fluidics devices and assemblies allowing for fluid flow between a plurality of wells. The fluidics devices and assemblies that are provided mimic in vivo tissue environments by allowing for initially segregated tissue cultures that can then be linked through fluid flow to measure integrated tissue response. The fluidics devices and assemblies provide a pumpless system using surface tension, gravity, and channel geometries. By linking human tissue functional systems to better simulate in vivo feedback and response signals between the tissues, the need for testing in animals can be minimized.
    Type: Grant
    Filed: November 26, 2016
    Date of Patent: November 28, 2017
    Assignee: SciKon Innovation, Inc.
    Inventors: Randall Edwin McClelland, David J. Sloan, Timothy C. Jensen, Maureen Kay Bunger
  • Publication number: 20170102404
    Abstract: Disclosed are fluidics devices and assemblies allowing for fluid flow between a plurality of wells. The fluidics devices and assemblies that are provided mimic in vivo tissue environments by allowing for initially segregated tissue cultures that can then be linked through fluid flow to measure integrated tissue response. The fluidics devices and assemblies provide a pumpless system using surface tension, gravity, and channel geometries. By linking human tissue functional systems to better simulate in vivo feedback and response signals between the tissues, the need for testing in animals can be minimized.
    Type: Application
    Filed: November 26, 2016
    Publication date: April 13, 2017
    Inventors: Randall Edwin McClelland, David J. Sloan, Timothy C. Jensen, Maureen Kay Bunger
  • Publication number: 20160334388
    Abstract: A basket for use with a fluidics device for simulating in vivo membrane permeation and response is provided. The basket includes an impermeable surface defining a bottom aperture for positioning within the host fluid of the dosing well of the fluidics device. Further, the basket further includes a permeable membrane positioned within the basket and covering the bottom aperture. Additionally, the basket includes a layer covering at least a portion of the membrane covering the bottom aperture for exposing a bottom side of the layer to the host fluid and for preventing an opposing top side of the layer from being exposed to the host fluid. A dose may be placed in contact with the layer for analyzing downstream permeations and responses.
    Type: Application
    Filed: June 15, 2016
    Publication date: November 17, 2016
    Inventors: Randall Edwin McClelland, David J. Sloan, Timothy C. Jensen
  • Publication number: 20040038378
    Abstract: An isolated B1 domain polypeptide of bacterial Protein G which binds a Fab fragment of an IgG but substantially does not bind a Fc fragment of an IgG. Methods for the detection and purification of IgG Fc antibody fragments and Fab antibody fragments using the isolated GB1 domain polypeptides are also disclosed.
    Type: Application
    Filed: September 25, 2003
    Publication date: February 26, 2004
    Inventors: Homme W. Hellinga, David J. Sloan
  • Patent number: 6663862
    Abstract: An isolated B1 domain polypeptide of bacterial Protein G which binds a Fab fragment of an IgG but substantially does not bind a Fc fragment of an IgG. Methods for the detection and purification of IgG Fc antibody fragments and Fab antibody fragments using the isolated GB1 domain polypeptides are also disclosed.
    Type: Grant
    Filed: June 4, 1999
    Date of Patent: December 16, 2003
    Assignee: Duke University
    Inventors: Homme W. Hellinga, David J. Sloan